Try The Drug Club risk-free for 30 days Trial terms

Endometrial Cancer (POLE-Mutant) Medication Savings with TheDrugClub

Members can check active-formulary eligibility and membership pricing for Endometrial Cancer (POLE-Mutant) medications. A condition association alone does not establish coverage.

What Is Endometrial Cancer (POLE-Mutant)?

Endometrial Cancer (POLE-Mutant) is a medical condition that may require prescription treatment. Consult a healthcare professional about appropriate options.

Managing Endometrial Cancer (POLE-Mutant) with TheDrugClub

Eligible medications linked to the active formulary may have no additional cost under listed supply, quantity, fill, and fulfillment limits. Other prescriptions may qualify for membership pricing. Confirm current terms before filling.

  1. Join TheDrugClub as a member
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available membership pricing

About Endometrial Cancer (the broader condition)

This summary describes Endometrial Cancer, the broader condition. Endometrial Cancer (POLE-Mutant) is a more specific topic.

What is uterine cancer?

Uterine cancer is a cancer that forms in tissues of the uterus, which is sometimes called the womb. The uterus is the place where a fetus grows during pregnancy.

There are two types of uterine cancer:

Endometrial cancer is the most common type. This type of cancer begins in the cells lining the uterus, known as the endometrium.

Uterine sarcoma is a rare, more aggressive cancer that is harder to treat. This type of cancer begins in muscle or other tissues in the uterus.

Who is more likely to develop uterine cancer?

Uterine cancer usually happens after menopause. The cause is unknown. However, some factors and conditions that change the balance of hormones in your body may increase your risk. These can include obesity or metabolic syndrome (a group of risk factors for certain health problems).

Other factors and conditions that may increase your risk for:

Endometrial cancer

Taking estrogen-only hormone therapy after menopause.

Having type 2 diabetes

Starting menstruation at an early age or menopause at a later age

Having never been pregnant

Taking tamoxifen, a medicine used to prevent or treat breast cancer

Having polycystic ovary syndrome

Having a mother, sister, or daughter who has had endometrial cancer

Having certain genetic conditions, such as Lynch syndrome

Having endometrial hyperplasia (thickening of the uterine lining)

Uterine sarcoma

Having had past treatment with radiation therapy to the pelvis

Taking tamoxifen, a medicine used to prevent or treat breast cancer

What are the symptoms of uterine cancer?

The most common symptom of both endometrial cancer and uterine sarcoma is abnormal vaginal bleeding. Both types of uterine cancer may also cause pelvic pain or pressure, unusual vaginal discharge, or an enlarged uterus or pelvic mass.

Less common symptoms may include urinating (peeing) often, having trouble urinating, or pain during sexual intercourse.

How is uterine cancer diagnosed?

If you have symptoms of uterine cancer, your health care provider may:

Ask about your medical history and family health history

Do a pelvic exam

Order imaging tests

Suggest a biopsy or a minor procedure called dilation and curettage (D & C) to check the lining of your uterus

What are the treatments for uterine cancer?

Treatment may depend on your health, how much cancer you have, and whether it has spread. The most common treatment is having a hysterectomy, which is surgery to remove the uterus. Sometimes the surgery also removes the ovaries and fallopian tubes.

You may have more than one type of treatment. Other treatments may include:

Hormone therapy

Radiation therapy

Chemotherapy

Can uterine cancer be prevented?

There is no sure way to prevent uterine cancer. But you can do things that may help lower your risk such as aiming for a healthy weight, getting regular physical activity, and talking to your provider about the benefits and risks of hormone therapy.

NIH: National Cancer Institute

Source: MedlinePlus, U.S. National Library of Medicine. MedlinePlus topic page. Topic date: 03/26/1999. MedlinePlus file date: 10/15/2026 02:30:37.

This information is educational and is not medical advice.

Related conditions

Participating pharmacy savings paths

Directory filing for Endometrial Cancer (POLE-Mutant)

In our directory, Endometrial Cancer (POLE-Mutant) is filed under Oncology - Staging.

Other pages filed under Oncology - Staging that share a word in the page name are listed here. Filing them together does not mean they are the same condition.

Start Your Risk-Free Trial
Start Your Risk-Free Trial